Ascentage Competitors

ASPHF Stock  USD 8.48  0.00  0.00%   
Ascentage Pharma competes with Galenica, and Sugi Holdings; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Ascentage Pharma competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Ascentage Pharma to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Ascentage Pharma Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Ascentage Pharma competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
6.038.4810.93
Details
Intrinsic
Valuation
LowRealHigh
4.697.149.59
Details
Naive
Forecast
LowNextHigh
6.148.5911.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
8.068.979.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ascentage Pharma. Your research has to be compared to or analyzed against Ascentage Pharma's peers to derive any actionable benefits. When done correctly, Ascentage Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ascentage Pharma.

Ascentage Pharma Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ascentage Pharma and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Ascentage and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ascentage Pharma does not affect the price movement of the other competitor.

High positive correlations

TKBIFMPSYF
GALNFMPSYF
INVVYMPSYF
SGIPFMPSYF
AAPGVMPSYF
IZQVFMPSYF
  

High negative correlations

ABCZFBIESF
ABCZFANHGY
BIESFANHGY
ABCZFIZQVF
BIESFIZQVF
ANHGYIZQVF

Risk-Adjusted Indicators

There is a big difference between Ascentage Pink Sheet performing well and Ascentage Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ascentage Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MPSYF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TKBIF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GALNF  1.47  0.65  0.00  0.51  0.00 
 0.00 
 39.53 
INVVY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SGIPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
AAPGV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IZQVF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANHGY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BIESF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ABCZF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Ascentage Pharma Competitive Analysis

The better you understand Ascentage Pharma competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ascentage Pharma's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ascentage Pharma's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ASPHF GALNF SGIPF BIESF ABCZF
 0.00 
 8.48 
Ascentage
 10.66 
 116.19 
Galenica
 0.00 
 16.29 
Sugi
 0.00 
 32.00 
Biotest
 0.00 
 22.25 
Abcam
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Daily Balance Of Power
Day Typical Price
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

Ascentage Pharma Competition Performance Charts

Five steps to successful analysis of Ascentage Pharma Competition

Ascentage Pharma's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ascentage Pharma in relation to its competition. Ascentage Pharma's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ascentage Pharma in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ascentage Pharma's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ascentage Pharma, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ascentage Pharma position

In addition to having Ascentage Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sport Products Thematic Idea Now

Sport Products
Sport Products Theme
Companies manufacturing sporting goods and accessories. The Sport Products theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Ascentage Pink Sheet

When determining whether Ascentage Pharma is a strong investment it is important to analyze Ascentage Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascentage Pharma's future performance. For an informed investment choice regarding Ascentage Pink Sheet, refer to the following important reports:
Check out Ascentage Pharma Correlation with its peers.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Please note, there is a significant difference between Ascentage Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascentage Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascentage Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.